FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/08/2026
Voltar para busca
Dado oficial do USPTO
VIXXA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
VIXXA
ST13
US500000079426642Classe
5, 9, 10, 35
Pedido
79426642
Registro
8105889
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
26
Atualização mais recente
06/08/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 9, 10, 35
Data de depósito
26/02/2025
Data de registro
20/01/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
20/01/2026
Última transação
06/08/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
Guildford, Surrey GU3 2DX, GB
Examinador
LAM, HAI-LY HUYNH
Unidade examinadora
N10
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
GlucoRx Ltd
Representantes
M. David Galin Tucker Ellis LLP
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 10Classe 35
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Test strips for measuring blood glucose levels; diagnostic preparations for medical purposes; nutraceutical preparations for therapeutic or medical purposesfor the treatment of diabetes; pharmaceutical preparations for the treatment of managing blood sugar levels and diabetes; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for treating diabetes; anti-diabetic pharmaceuticals; anti-diabetic preparations; dietetic foods adapted for medical purposes; veterinary diagnostic reagents; medical diagnostic reagents; reagents for use in metabolic syndrome diagnostic tests for medical purposes; massage creams for medical purposes; insulin injectors sold filled with insulin; analytes test stripsmedical diagnostic test strips for blood analysismedical diagnostic test strips for urine analysis
Classe 9
Downloadable computer software for use by one or more individuals to acquirereceivestoreprocessanalyseaccesspresentreport and transmit medical and physiological data; downloadable software applications for mobile devices for monitoring and managing patient medical information; apparatus and instruments for receiving and storing sound and data in digital formdigital computerscomputer hardware; recorded computer software for monitoring an individual's blood pressureweightheart rate and respiratory events; downloadable computer software using artificial intelligence for machine learning in the field of healthcare; recorded computer software using artificial intelligence for remote monitoring of medical data for medical diagnosis and treatment
Classe 10
Medical devices for medical and surgical usemedical test kits for diabetes monitoring; medicalweight managementlifestyle and wellness devices for human and veterinary purposeselectrical weight loss body belttherapeutic compression wraps; sensors that are implanted or inserted into the body used to continuously monitor the concentration of physiological analytes in the body for medical purposes; non-invasive sensors that are used to continuously monitor the concentration of physiological analytes in the body and associated accessoriesreceiverssensor housings and sensor insertion devicesall for medical purposes; medical apparatus and instrumentsblood pressure monitorsblood glucose monitors; analytes measuring metersblood glucose meters; pumps for medical purposespumps for use in delivering pharmaceuticals from containers; medical apparatus for monitoring vital signs of patients; patient monitoring sensors and alarms for medical purposes; cytometers for medical diagnostic use; patient examination tables; diagnostic apparatus for medical useultrasound diagnostic apparatusglucose monitoring apparatus; medical apparatus and instruments for monitoring electrocardiographycarbon dioxide levelsoxygen saturationexercise and activity heart ratescardiac activityrespiratory events; pulse metersheart rate monitoring apparatus and body composition monitors
Classe 35
Online advertising on a computer network; advertising services; commercial administration of the licensing of the goods and services of others; providing business information via a website; sales promotion for others; provision of an online marketplace for buyers and sellers of goods and services; import-export agency services; updating and maintenance of data in computer databases; wholesale and retail store services featuring pharmaceuticals; business auditing
Publicações
Histórico de despachos e eventos da marca no USPTO.
26 publicações encontradas
FIMP
FINAL DISPOSITION PROCESSED
06/08/2026
CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
06/08/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
20/04/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
20/01/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
20/01/2026
GPNX
NOTIFICATION PROCESSED BY IB
19/12/2025
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
18/12/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/12/2025
PUBO
PUBLISHED FOR OPPOSITION
02/12/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
26/11/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
26/11/2025
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
25/11/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/11/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/10/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/10/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/10/2025
RFNT
REFUSAL PROCESSED BY IB
03/10/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/09/2025
RFRR
REFUSAL PROCESSED BY MPU
10/09/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/08/2025
CNRT
NON-FINAL ACTION WRITTEN
31/07/2025
DOCK
ASSIGNED TO EXAMINER
31/07/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/07/2025
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
30/06/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
26/06/2025
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace VIXXA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.